Spero Therapeutics, Inc.
SPRONasdaqCIK 1701108HealthcareFiscal year ends Dec 31
Reports and events: 174 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-03-1116:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-077864 |
| 2021-03-1116:14 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-012514 |
| 2021-02-1617:29 ET | SC 13D/A | Ownership report, active investor, amended | 0001839882-21-002172 |
| 2021-02-0508:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-029880 |
| 2021-01-1908:01 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-21-010857 |
| 2020-12-1708:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-319592 |
| 2020-12-0307:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-308948 |
| 2020-11-0516:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-286841 |
| 2020-11-0516:01 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-051279 |
| 2020-10-2816:06 ET | 8-K | 5.07 Shareholder vote results | 0001193125-20-279790 |
| 2020-09-3016:23 ET | DEF 14A | Proxy statementPeriod 2020-10-27 | 0001193125-20-259653 |
| 2020-09-1608:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-246775 |
| 2020-09-1409:26 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-244804 |
| 2020-09-0916:48 ET | 8-K | 8.01 Other events | 0001193125-20-242243 |
| 2020-09-0807:43 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-240546 |
| 2020-08-0616:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-211931 |
| 2020-08-0616:02 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-037710 |
| 2020-06-0409:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-160206 |
| 2020-05-1116:53 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-20-139200 |
| 2020-05-0808:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-137009 |
| 2020-05-0807:51 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001564590-20-023243 |
| 2020-04-1608:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-20-108749 |
| 2020-03-1608:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-073981 |
| 2020-03-1608:23 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001564590-20-010998 |
| 2020-02-2816:31 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-056529 |
| 2020-02-1108:30 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-030705 |
| 2020-01-3008:08 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-019086 |
| 2019-12-1917:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-19-319256 |
| 2019-12-0508:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-306821 |
| 2019-11-0416:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-283355 |
| 2019-11-0416:01 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001564590-19-039770 |
| 2019-10-0312:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-261358 |
| 2019-09-0608:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-19-239450 |
| 2019-08-0816:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-216834 |
| 2019-08-0816:01 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001564590-19-030746 |
| 2019-06-1308:13 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-19-171876 |
| 2019-06-0616:40 ET | 8-K | 5.07 Shareholder vote results | 0001193125-19-167255 |
| 2019-05-0916:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-142982 |
| 2019-05-0916:01 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001564590-19-017941 |
| 2019-04-2616:22 ET | DEF 14A | Proxy statementPeriod 2019-06-05 | 0001193125-19-122422 |
| 2019-04-1817:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-19-111025 |
| 2019-03-2916:54 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-19-092830 |
| 2019-03-1908:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-19-078993 |
| 2019-03-1416:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-074792 |
| 2019-03-1416:04 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001564590-19-007805 |
| 2019-01-0717:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-003882 |
| 2018-11-1609:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-18-328530 |
| 2018-11-1308:46 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-324949 |
| 2018-11-0816:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-322565 |
| 2018-11-0816:02 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001564590-18-028526 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.